nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—ABCB1—Parkinson's disease	0.876	1	CbGaD
Norethindrone—Nandrolone decanoate—MAOB—Parkinson's disease	0.00397	0.334	CrCbGaD
Norethindrone—Nandrolone decanoate—MAOA—Parkinson's disease	0.00278	0.234	CrCbGaD
Norethindrone—Testosterone Propionate—COMT—Parkinson's disease	0.00253	0.212	CrCbGaD
Norethindrone—Testosterone—MAOA—Parkinson's disease	0.000827	0.0694	CrCbGaD
Norethindrone—Ethinyl Estradiol—ABCB1—Parkinson's disease	0.000505	0.0424	CrCbGaD
Norethindrone—Progesterone—CYP2D6—Parkinson's disease	0.000396	0.0333	CrCbGaD
Norethindrone—Hydrocortisone—ABCB1—Parkinson's disease	0.000347	0.0292	CrCbGaD
Norethindrone—Progesterone—ABCB1—Parkinson's disease	0.000283	0.0238	CrCbGaD
Norethindrone—Testosterone—ABCB1—Parkinson's disease	0.000267	0.0225	CrCbGaD
Norethindrone—ALB—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000129	0.00115	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	0.000127	0.00114	CbGpPWpGaD
Norethindrone—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.000125	0.00112	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.000125	0.00112	CbGpPWpGaD
Norethindrone—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000124	0.0011	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—HSPA8—Parkinson's disease	0.000123	0.0011	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—CTGF—Parkinson's disease	0.000123	0.0011	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PDYN—Parkinson's disease	0.000123	0.0011	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	0.000121	0.00108	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GBA—Parkinson's disease	0.000121	0.00108	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—DBH—Parkinson's disease	0.000121	0.00108	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—FBP1—Parkinson's disease	0.000121	0.00108	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.00012	0.00107	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	0.00012	0.00107	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	0.000119	0.00107	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000118	0.00105	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—GFAP—Parkinson's disease	0.000115	0.00103	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ND3—Parkinson's disease	0.000115	0.00103	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MCCC1—Parkinson's disease	0.000115	0.00103	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—TNF—Parkinson's disease	0.000114	0.00102	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	0.000114	0.00102	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—GRM5—Parkinson's disease	0.000114	0.00102	CbGpPWpGaD
Norethindrone—ALB—Vitamin B12 Metabolism—IL6—Parkinson's disease	0.000113	0.00101	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—HSPA1A—Parkinson's disease	0.000112	0.001	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000109	0.000972	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—TALDO1—Parkinson's disease	0.000108	0.000966	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—OMD—Parkinson's disease	0.000108	0.000966	CbGpPWpGaD
Norethindrone—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000107	0.000958	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000105	0.000939	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000105	0.000934	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—NDUFB11—Parkinson's disease	0.000102	0.000915	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—FGF20—Parkinson's disease	0.0001	0.000894	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.0001	0.000893	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	9.95e-05	0.000889	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ND3—Parkinson's disease	9.9e-05	0.000885	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MCCC1—Parkinson's disease	9.9e-05	0.000885	CbGpPWpGaD
Norethindrone—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	9.81e-05	0.000876	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GCH1—Parkinson's disease	9.77e-05	0.000873	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—ADORA2A—Parkinson's disease	9.7e-05	0.000867	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	9.44e-05	0.000843	CbGpPWpGaD
Norethindrone—ALB—Metabolism—TALDO1—Parkinson's disease	9.31e-05	0.000832	CbGpPWpGaD
Norethindrone—ALB—Metabolism—OMD—Parkinson's disease	9.31e-05	0.000832	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—IL6—Parkinson's disease	9.23e-05	0.000824	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	9.2e-05	0.000822	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	9.08e-05	0.000812	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—INSR—Parkinson's disease	8.95e-05	0.0008	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MCCC1—Parkinson's disease	8.89e-05	0.000794	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ND3—Parkinson's disease	8.89e-05	0.000794	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—DDC—Parkinson's disease	8.85e-05	0.00079	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—FGB—Parkinson's disease	8.84e-05	0.00079	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NDUFB11—Parkinson's disease	8.82e-05	0.000788	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	8.76e-05	0.000783	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—DBH—Parkinson's disease	8.71e-05	0.000778	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—FBP1—Parkinson's disease	8.71e-05	0.000778	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GBA—Parkinson's disease	8.71e-05	0.000778	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—TNF—Parkinson's disease	8.68e-05	0.000775	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MCCC1—Parkinson's disease	8.67e-05	0.000775	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ND3—Parkinson's disease	8.67e-05	0.000775	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—FGB—Parkinson's disease	8.46e-05	0.000756	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GCH1—Parkinson's disease	8.42e-05	0.000752	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—HTR1A—Parkinson's disease	8.42e-05	0.000752	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—TALDO1—Parkinson's disease	8.36e-05	0.000747	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—OMD—Parkinson's disease	8.36e-05	0.000747	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GSTA4—Parkinson's disease	8.35e-05	0.000746	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TAC1—Parkinson's disease	8.29e-05	0.000741	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—COMT—Parkinson's disease	8.24e-05	0.000736	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	8.2e-05	0.000733	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	8.18e-05	0.000731	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—TALDO1—Parkinson's disease	8.16e-05	0.000729	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—OMD—Parkinson's disease	8.16e-05	0.000729	CbGpPWpGaD
Norethindrone—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	8.13e-05	0.000726	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—DRD1—Parkinson's disease	8.13e-05	0.000726	CbGpPWpGaD
Norethindrone—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	8.09e-05	0.000723	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	8.06e-05	0.00072	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	7.92e-05	0.000708	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—DRD3—Parkinson's disease	7.87e-05	0.000703	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NDUFB11—Parkinson's disease	7.73e-05	0.000691	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	7.59e-05	0.000678	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GCH1—Parkinson's disease	7.56e-05	0.000675	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	7.54e-05	0.000673	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PLA2G6—Parkinson's disease	7.52e-05	0.000672	CbGpPWpGaD
Norethindrone—ALB—Metabolism—FBP1—Parkinson's disease	7.5e-05	0.00067	CbGpPWpGaD
Norethindrone—ALB—Metabolism—DBH—Parkinson's disease	7.5e-05	0.00067	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GBA—Parkinson's disease	7.5e-05	0.00067	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—MAOB—Parkinson's disease	7.45e-05	0.000665	CbGpPWpGaD
Norethindrone—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	7.43e-05	0.000664	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GCH1—Parkinson's disease	7.38e-05	0.000659	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—ADRBK1—Parkinson's disease	7.35e-05	0.000657	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	7.33e-05	0.000655	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—DRD2—Parkinson's disease	7.12e-05	0.000636	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—HTR7—Parkinson's disease	7.12e-05	0.000636	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	6.82e-05	0.000609	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GBA—Parkinson's disease	6.74e-05	0.000602	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—FBP1—Parkinson's disease	6.74e-05	0.000602	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—DBH—Parkinson's disease	6.74e-05	0.000602	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—FBP1—Parkinson's disease	6.57e-05	0.000587	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GBA—Parkinson's disease	6.57e-05	0.000587	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—DBH—Parkinson's disease	6.57e-05	0.000587	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—SOD1—Parkinson's disease	6.57e-05	0.000587	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.56e-05	0.000586	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—DDC—Parkinson's disease	6.39e-05	0.000571	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.29e-05	0.000562	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—ABL1—Parkinson's disease	6.26e-05	0.00056	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IGF2—Parkinson's disease	6.24e-05	0.000557	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTA4—Parkinson's disease	6.04e-05	0.00054	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IGF2—Parkinson's disease	5.97e-05	0.000533	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—HGF—Parkinson's disease	5.89e-05	0.000526	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	5.89e-05	0.000526	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IGF1R—Parkinson's disease	5.77e-05	0.000515	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.74e-05	0.000513	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—EDN1—Parkinson's disease	5.7e-05	0.000509	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYP2D6—Parkinson's disease	5.53e-05	0.000494	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	5.51e-05	0.000493	CbGpPWpGaD
Norethindrone—ALB—Metabolism—DDC—Parkinson's disease	5.51e-05	0.000492	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.47e-05	0.000489	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	5.44e-05	0.000486	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CTGF—Parkinson's disease	5.43e-05	0.000485	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	5.41e-05	0.000483	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MAOB—Parkinson's disease	5.38e-05	0.000481	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MCCC1—Parkinson's disease	5.34e-05	0.000477	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ND3—Parkinson's disease	5.34e-05	0.000477	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	5.25e-05	0.000469	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NGF—Parkinson's disease	5.24e-05	0.000468	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTA4—Parkinson's disease	5.2e-05	0.000465	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	5.13e-05	0.000459	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	5.06e-05	0.000452	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—OMD—Parkinson's disease	5.02e-05	0.000449	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—TALDO1—Parkinson's disease	5.02e-05	0.000449	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—NQO1—Parkinson's disease	5e-05	0.000447	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—HTR2A—Parkinson's disease	4.99e-05	0.000445	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—DDC—Parkinson's disease	4.94e-05	0.000442	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—TH—Parkinson's disease	4.93e-05	0.000441	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—DDC—Parkinson's disease	4.83e-05	0.000431	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.79e-05	0.000428	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.76e-05	0.000426	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYCS—Parkinson's disease	4.74e-05	0.000423	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PLA2G6—Parkinson's disease	4.68e-05	0.000418	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTA4—Parkinson's disease	4.67e-05	0.000417	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—APOE—Parkinson's disease	4.64e-05	0.000414	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MAOB—Parkinson's disease	4.64e-05	0.000414	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.61e-05	0.000412	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTA4—Parkinson's disease	4.56e-05	0.000407	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GCH1—Parkinson's disease	4.54e-05	0.000406	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	4.41e-05	0.000394	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	4.28e-05	0.000383	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	4.2e-05	0.000376	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—COMT—Parkinson's disease	4.19e-05	0.000375	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GSTP1—Parkinson's disease	4.17e-05	0.000373	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—MAOA—Parkinson's disease	4.16e-05	0.000372	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MAOB—Parkinson's disease	4.16e-05	0.000372	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—HMOX1—Parkinson's disease	4.12e-05	0.000368	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PLA2G6—Parkinson's disease	4.1e-05	0.000367	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MAOB—Parkinson's disease	4.06e-05	0.000363	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GBA—Parkinson's disease	4.05e-05	0.000362	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—DBH—Parkinson's disease	4.05e-05	0.000362	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—FBP1—Parkinson's disease	4.05e-05	0.000362	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	4e-05	0.000357	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.96e-05	0.000354	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—INS—Parkinson's disease	3.96e-05	0.000354	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ABCB1—Parkinson's disease	3.95e-05	0.000353	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CTGF—Parkinson's disease	3.93e-05	0.000351	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GSTM1—Parkinson's disease	3.84e-05	0.000343	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GPX1—Parkinson's disease	3.67e-05	0.000328	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	3.66e-05	0.000327	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—NQO1—Parkinson's disease	3.62e-05	0.000323	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—TH—Parkinson's disease	3.57e-05	0.000319	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP2D6—Parkinson's disease	3.45e-05	0.000308	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYCS—Parkinson's disease	3.42e-05	0.000306	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—MTHFR—Parkinson's disease	3.39e-05	0.000303	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CTGF—Parkinson's disease	3.38e-05	0.000302	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—APOE—Parkinson's disease	3.16e-05	0.000282	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP2E1—Parkinson's disease	3.15e-05	0.000282	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NQO1—Parkinson's disease	3.12e-05	0.000278	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	3.09e-05	0.000276	CbGpPWpGaD
Norethindrone—ALB—Metabolism—TH—Parkinson's disease	3.07e-05	0.000274	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CTGF—Parkinson's disease	3.04e-05	0.000271	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—COMT—Parkinson's disease	3.03e-05	0.000271	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP2D6—Parkinson's disease	3.02e-05	0.00027	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTP1—Parkinson's disease	3.02e-05	0.00027	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MAOA—Parkinson's disease	3.01e-05	0.000269	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—HMOX1—Parkinson's disease	2.98e-05	0.000266	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—DDC—Parkinson's disease	2.97e-05	0.000266	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CTGF—Parkinson's disease	2.96e-05	0.000265	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CASP3—Parkinson's disease	2.95e-05	0.000263	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYCS—Parkinson's disease	2.95e-05	0.000263	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ABCB1—Parkinson's disease	2.86e-05	0.000255	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	2.83e-05	0.000253	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.81e-05	0.000251	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NQO1—Parkinson's disease	2.8e-05	0.00025	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTM1—Parkinson's disease	2.77e-05	0.000248	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP2E1—Parkinson's disease	2.76e-05	0.000247	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—TH—Parkinson's disease	2.76e-05	0.000246	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NQO1—Parkinson's disease	2.73e-05	0.000244	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK8—Parkinson's disease	2.71e-05	0.000242	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—INS—Parkinson's disease	2.7e-05	0.000241	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—TH—Parkinson's disease	2.69e-05	0.00024	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GPX1—Parkinson's disease	2.66e-05	0.000237	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYCS—Parkinson's disease	2.65e-05	0.000236	CbGpPWpGaD
Norethindrone—ALB—Metabolism—COMT—Parkinson's disease	2.61e-05	0.000233	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTP1—Parkinson's disease	2.6e-05	0.000232	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MAOA—Parkinson's disease	2.59e-05	0.000232	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYCS—Parkinson's disease	2.58e-05	0.000231	CbGpPWpGaD
Norethindrone—ALB—Metabolism—HMOX1—Parkinson's disease	2.56e-05	0.000229	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.53e-05	0.000226	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.5e-05	0.000224	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ABCB1—Parkinson's disease	2.46e-05	0.00022	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MTHFR—Parkinson's disease	2.45e-05	0.000219	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTM1—Parkinson's disease	2.39e-05	0.000213	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—COMT—Parkinson's disease	2.34e-05	0.000209	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTP1—Parkinson's disease	2.33e-05	0.000208	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MAOA—Parkinson's disease	2.33e-05	0.000208	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HMOX1—Parkinson's disease	2.3e-05	0.000206	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—COMT—Parkinson's disease	2.29e-05	0.000204	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GPX1—Parkinson's disease	2.29e-05	0.000204	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOE—Parkinson's disease	2.28e-05	0.000204	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.28e-05	0.000203	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MAOA—Parkinson's disease	2.27e-05	0.000203	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.25e-05	0.000201	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ABCB1—Parkinson's disease	2.21e-05	0.000197	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTM1—Parkinson's disease	2.14e-05	0.000192	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MTHFR—Parkinson's disease	2.11e-05	0.000189	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.09e-05	0.000187	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GPX1—Parkinson's disease	2.05e-05	0.000183	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GPX1—Parkinson's disease	2e-05	0.000179	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOE—Parkinson's disease	1.96e-05	0.000176	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—INS—Parkinson's disease	1.95e-05	0.000174	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.89e-05	0.000169	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.86e-05	0.000166	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.85e-05	0.000165	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.83e-05	0.000163	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOE—Parkinson's disease	1.76e-05	0.000158	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6—Parkinson's disease	1.73e-05	0.000155	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOE—Parkinson's disease	1.72e-05	0.000154	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.7e-05	0.000152	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.68e-05	0.00015	CbGpPWpGaD
Norethindrone—ALB—Metabolism—INS—Parkinson's disease	1.68e-05	0.00015	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—TH—Parkinson's disease	1.66e-05	0.000148	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.59e-05	0.000142	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—INS—Parkinson's disease	1.51e-05	0.000135	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—INS—Parkinson's disease	1.47e-05	0.000131	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—COMT—Parkinson's disease	1.41e-05	0.000126	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.4e-05	0.000125	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.4e-05	0.000125	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.38e-05	0.000124	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.33e-05	0.000119	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.29e-05	0.000115	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.23e-05	0.00011	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.14e-05	0.000102	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOE—Parkinson's disease	1.06e-05	9.48e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—INS—Parkinson's disease	9.06e-06	8.09e-05	CbGpPWpGaD
